Current Report Filing (8-k)
July 31 2019 - 4:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
July 31, 2019
|
|
|
Date of report (Date of earliest event reported)
|
|
|
Surmodics, Inc.
|
|
|
(Exact Name of Registrant as Specified in its Charter)
|
|
Minnesota
|
|
0-23837
|
|
41-1356149
|
(State of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
9924 West 74
th
Street
Eden Prairie, Minnesota
|
|
55344
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
(952) 500-7000
|
|
|
(Registrant’s Telephone Number, Including Area Code)
|
|
Check the appropriate box below if the Form 8‑K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a‑12 under the Exchange Act (17 CFR 240.14a‑12)
☐ Pre‑commencement communications pursuant to Rule 14d‑2(b) under the Exchange Act (17 CFR 240.14d‑2(b))
☐ Pre‑commencement communications pursuant to Rule 13e‑4(c) under the Exchange Act (17 CFR 240.13e‑4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
|
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
☐
|
Item 2.02
Results of Operations and Financial Condition.
On July 31, 2019, Surmodics, Inc. (the “
Company
”)
issued a press release (the “
Press Release
”) announcing the results for the quarter ended June 30, 2019. A copy of the full text of the Press Release is
furnished as Exhibit 99.1 to this report.
The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, nor shall they be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01
Financial Statements and Exhibits.
(d)
Exhibits
.
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
Press Release dated July 31, 2019.
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
SURMODICS, INC.
|
|
|
|
|
|
|
|
|
|
Date: July 31, 2019
|
/s/ Timothy J. Arens
|
|
|
Timothy J. Arens
|
|
|
Vice President of Finance and Chief Financial Officer
|
|
|
|
|
|
EXHIBIT INDEX
Exhibit Number
|
|
Description
|
|
|
|
|
|
|
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024